117946-91-5
117946-91-5 结构式
基本信息
N-乙酰-2-苄基色胺
N-乙酰基-2-苄基色胺
N-乙酰-2-苄基色胺溶液,100PPM
LUZINDOLE N-乙酰基-2-苄基色胺
N-(2-(2-苄基-1H-吲哚-3-基)乙基)乙酰胺
N-[2-[2-(苯基甲基)-1H-吲哚-3-基]乙基]乙酰胺
物理化学性质
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/04/30 | HY-101254 | N-乙酰-2-苄基色胺 Luzindole | 117946-91-5 | 1mg | 760元 |
| 2024/04/30 | L0316 | N-乙酰基-2-苄基色胺 Luzindole | 117946-91-5 | 25mg | 1450元 |
| 2024/04/30 | HY-101254 | N-乙酰-2-苄基色胺 Luzindole | 117946-91-5 | 5mg | 1900元 |
常见问题列表
Ki :10.2 nM (human MT2), 158 nM (human MT1)
Luzindole (N-0774) (5-10 μg/ml) inhibits antigen-specific proliferation of the MBP-reactive LV-4 T cell line.
Luzindole (N-0774) (30 mg/kg; i.p.; days 0-5) suppresses experimental autoimmune encephalomyelitis.
Luzindole (N-0774) (30 mg/kg i.p.) reduces the time of immobility in a dose-dependent manner, the effect being more pronounced at midnight (60% reduction) than at noon (39% reduction). The effect of luzindole is time-dependent, showing a maximal effect at 60 min. The anti-immobility effect of luzindole (10 mg/kg i.p.) is prevented by the administration of melatonin (30 mg/kg i.p.). Luzindole (30 mg/kg i.p.) did not modify the time of immobility either at noon or midnight in the albino ND/4 mouse, or in the C57BL/6J mouse, which does not produce melatonin.
| Animal Model: | Twenty-three- to 12-week-old(SJL X PL/J ) F1 mice |
| Dosage: | 30 mg/kg |
| Administration: | i.p.; days 0-5 (between 23: 00 and 1: 00 under conditions of minimal lighting) |
| Result: | Effectively prevented experimental autoimmune encephalomyelitis. |